In patients with OI, mutations in COL1A1 or COL1A2 result in increased bone fragility.113 Moreover, Col1a1 mutant mouse have reduced overall body fat content,113 suggesting that these mice have lower levels of adiponectin — although this was not explicitly measured. The gene discussed is COL1A1; the disease is osteogenesis imperfecta.